Arthritis Pain gateway features information on dealing with chronic pain. Understanding Your Pain. Managing Your Pain.
Latest Articles
Arthritis In Dogs - Tips To Prevent This Crippling Canine DiseaseArthritis is a general term for abnormal changes to a joint. Arthritis can occur when joint tissue is damaged from an infection, from congenital defects that affect the structural integrity and from stress and trauma to joint surfaces and...
Shoulder Hemiarthroplasty In Patients With Juvenile Idiopathic Arthritis
Replacement of the berm in juvenile person idiopathic arthritis is not often performed and at that place rich person been no published series to date. We present nine glenohumeral hemiarthroplasties in eight patients with systemic or ...
Symptoms of Arthritis
Symptoms of Arthritis In a previous article, we discussed what Arthritis is and its many forms, now it is time to take a look at the symptoms of Arthritis. Arthritis shows up in various ways. Some of the first symptoms include things like...
Cetyl Myristoleate for Arthritis Science or Speculation
Cetyl Myristoleate for ArthritisScience for Speculation
By Rusty Ford
There are a lot of fabulous stories about Cetyl Myristoleate (also known as CMO or CM) floating across the Internet. Mine is one of them. There have been a number of articles published in little known journals or magazines. There have been four small booklets published. One making fantastic claims, all four filled with anecdotal evidence but offering no real research to back up the claims. There are a number of Doctors sharing the results they are having with their patients but so does every other wonder-working product. The question is, are there any scientific studies to back up any of these claims? The answer is yes. To date there are several patient studies and two double blind studies completed. I will mention the three most prominent below.
Dr Len Sands of the San Diego Clinic completed the first human study on the effectiveness on Cetyl Myristoleate in 1995. There were 48 arthritis patients in this study. All but two showed significant improvement in articular mobility (80% or better) and reduction of pain (70% or better). Obviously the study had its flaws. One doctor conducted the study, there was no control group and the number of participants was small. Even so, it suggested to many that maybe there was some hope here and that more scientific studies should follow.
The first double blind study followed two years later. Dr. H. Siemandi conducted a double blind study under the auspices of the Joint European Hospital Studies Program. There were 431 patients in the study, 106 who received cetyl myristoleate, 99 who received cetyl myristoleate, and glucosamine, sea cucumber, and hydrolyzed cartilage and 226 who received a placebo. Clinical assessment included radiological test and other studies. Results were 63% improvement for the cetyl myristoleate group, 87% for the cetyl myristoleate plus glucosamine group and 15% for the placebo group.
In August of
2002, a double blind study was published in the Journal or Rheumatology. The study included sixty-four patients with chronic knee OA. Half of the patients received a cetyl myristoleate complex and half a placebo. Evaluations included physician assessment, knee range of motion with goniometry, and the Lequesne Algofunctional Index (LAI). The conclusion was that the CM group saw significant improvement while the placebo group saw little to none. In fact in their conclusion the state that CM “may be an alternative to the use of nonsteroidal anti-inflammatory drugs for the treatment of OA”.
Advanced Medical Systems & Design, Ltd completed the last study I would like to mention in Oct 2001. It was not a double blind study but the study included 1814 arthritis patients. The results showed that over 87% of the subjects had greater than 50% recovery and over 65% of those showed from 75% - 100% recovery following a sixteen day regimen. I know that this is not the most scientific study but a study this large does suggest that there could be a positive benefit to the use of CM in the treatment of arthritis.
Conclusion: There is mounting evidence that CM can be effective in the treatment of many forms of arthritis. While it is true that the evidence from these three studies can not be considered conclusive, it is a beginning. It should challenge you to think out side the box and consider that just because it did not come from a drug company does not mean that it will not work. With over 10,000 people a year dying from Nsaids would it not be great to find a safer and more effective product. Especially with the cost of prescription treatments for arthritis costing into the hundreds and good Cetyl Myristoleate products can be found for between $20 and $40.
Rusty Ford
http://arthritis-symptom.com
About the Author
Editor Arthritis-Symptom.com. Author of numerous articles on arthrits and natural health.
Written By: Rusty Ford
IMPORTANT: Bing News RSS feed has moved!
<table bgColor="#ffffbb" border="1px"><td>Go to the <a href="http://api.bing.com/rss.aspx?Source=News&Market=en-US&Version=2.0&Query=Arthritis">new RSS page</a> and renew your subscription.</td></table>
Alternative Therapies Offer
An estimated 50 million Americans are living with
Benitec Biopharma and Medistem Technologies Successfully Combined in Preclinical Stem Cell Therapy for Rheumatoid
Benitec Biopharma (ASX: BLT) and Medistem (PINKSHEETS: MEDS) announced today the successful treatment of rheumatoid
Tobacco Use And Rheumatoid
Too many rheumatoid
More than 40 percent of rheumatoid
Ultrasound makes
Ultrasound is transforming the way
Link between poor neighbourhoods and risk of
People living in poor neighbourhoods have a higher rate and risk of
